Bioorganic and Medicinal Chemistry Letters

Inactivation of serine protease, -chymotrypsin by fluorinated phenylalanine analogues
pp. 1875-1880(6)
Authors: Ohba T.; Ikeda E.; Takei H.

Conformational analysis of meropenem and desmethyl meropenem: the effect of 1-methyl group on carbapenem antibiotics
pp. 1881-1886(6)
Authors: Igarashi J.-e.; Nishimura T.; Sasaki A.; Sunagawa M.

Nucleosides and nucleotides. 152. 1-(3-C-ethynyl--D-ribo-pentofuranosyl)uracil as a broad spectrum antitumor nucleoside
pp. 1887-1892(6)
Authors: Matsuda A.; Hattori H.; Tanaka M.; Sasaki T.

Synthesis and activity of staurosporine analogs with a lactone functionality
pp. 1893-1896(4)
Authors: Yamada R.; Fukuda K.; Kawanishi M.; Ohmori Y.; Nasu M.; Seto M.; Sasaki Y.; Sunazuka T.; Zhuorong L.; Funato N.; Iguchi M.; Harigaya Y.; Iwai Y.; Omura S.

Synthesis of C-oxetanosyl-thiazole and its carbocyclic analog nucleosides as potential chemotherapeutic agents
pp. 1897-1900(4)
Authors: Kikuchi Y.; Nishiyama S.; Yamamura S.; Kato K.; Fujiwara S.; Umezawa K.; Terada Y.

Synthesis, characterization, and anti-HIV activity of some 2-p-X-phenyl-1,3-N,N'-diphenyl-amidines
pp. 1901-1904(4)
Authors: Echevarria A.; Santos L.H.; Miller J.; Mahmood N.

Rapid synthesis of novel dipeptide inhibitors of human collagenase and gelatinase using solid phase chemistry
pp. 1905-1910(6)
Authors: Foley M.A.; Hassman A.S.; Drewry D.H.; Greer D.G.; Wagner C.D.; Feldman P.L.; Berman J.; Bickett D.M.; McGeehan G.M.; Lambert M.H.; Green M.

Thiono triester modified antisense oligonucleotides for inhibition of human cytomegalovirus in vitro
pp. 1911-1916(6)
Authors: Zhang Z.; Smith J.A.; Smyth A.P.; Eisenberg W.; Pari G.S.; Tang J.Y.

Acyloxyaryl prodrugs of oligonucleoside phosphorothioates
pp. 1917-1922(6)
Authors: Iyer R.P.; Dong Y.; Devlin T.; Nan-hui H.; Agrawal S.

Synthesis of azido derivatives of semotiadil, a novel 1,4-benzothiazine calcium antagonist, for photoaffinity probes of calcium channels
pp. 1923-1926(4)
Authors: Watanabe Y.; Osanai K.; Nishi T.; Miyawaki N.; Shii D.; Honda T.; Shibano T.

Synthesis and acetylcholinesterase inhibitory activity of fluorinated analogues of huperzine A
pp. 1927-1930(4)
Authors: Kaneko S.; Nakajima N.; Shikano M.; Katoh T.; Terashima S.

Design of MHC class II (DR4) ligands using conformationally restricted imino acids at p3 and p5
pp. 1931-1936(6)
Authors: Hanson G.J.; Vuletich J.L.; Bedell L.J.; Bono C.P.; Howard S.C.; Welply J.K.; Woulfe S.L.; Zacheis M.L.

Aromatic P₁ replacements for the highly potent HIV-1 protease inhibitor CRIXIVAN(R)
pp. 1937-1940(4)
Authors: Coburn C.A.; Young M.B.; Hungate R.W.; Isaacs R.C.A.; Vacca J.P.; Huff J.R.

-dicarbonyls as ''non-charged'' arginine-directed affinity labels. Novel synthetic routes to -dicarbonyl analogs of the PP60^c-src SH2 domain-targeted phosphopeptide Ac-TYR (OPO₃H₂)-glu-glu-ile-glu
pp. 1941-1946(6)
Authors: Mehrotra M.M.; Sternbach D.D.; Rodriguez M.; Charifson P.; Berman J.

Stereoselective synthesis and biological activity of CIS azetidinones as cholesterol absorption inhibitors
pp. 1947-1950(4)
Authors: McKittrick B.A.; Ke M.; Dugar S.; Clader J.W.; Davis H.; Czarniecki M.; McPhail A.T.

Phosphonate-containing analogs of cholesteryl ester as novel inhibitors of cholesteryl ester transfer protein
pp. 1951-1954(4)
Authors: Pietzonka T.; Damon R.; Russell M.; Wattanasin S.

A Comparative Study Of The Solvolysis Reactivity, Regioselectivity, And Stereochemistry Of The Duocarmycin a And sa Alkylation Subunits
pp. 1955-1960(6)
Authors: Boger D.L.; Goldberg J.; McKie J.A.

Rapid assembly of ''subtiligase'' substrates to elucidate optimal ligation junctures
pp. 1961-1966(6)
Authors: Judice J.K.; Namenuk A.K.; Burnier J.P.

Pentamidine congeners. 4. DNA binding affinity and anti-pneumocystis carinii activity of butamidine analogues
pp. 1967-1970(4)
Authors: Donkor I.O.; Queener S.F.; Dalton J.T.

Target directed enediyne prodrugs: hER and AhR degradation by a synthetic oxo-enediyne
pp. 1971-1976(6)
Authors: Jones G.B.; Kilgore M.W.; Pollenz R.S.; Li A.; Mathews J.E.; Wright J.M.; Huber R.S.; Tate P.L.; Price T.L.; Sticca R.P.

A chiral recognition element with an unusual size constraint affects the potency and selectivity for peptidomimetic inhibitors of Candida albicans myristoyl-COA: protein N-myristoyltransferase
pp. 1977-1982(6)
Authors: Devadas B.; Freeman S.K.; McWherter C.A.; Kuneman D.W.; Vinjamoori D.V.; Sikorski J.A.

Synthesis of potential peptidomimetics based on highly substituted glucose and allose scaffolds.
pp. 1983-1988(6)
Authors: Le Diguarher T.; Boudon A.; Elwell C.; Paterson D.E.; Billington D.C.

p-Nitrophenyl 1,5-dithio--l-fucopyranoside: a novel sulfur based fucosidase inhibitor
pp. 1989-1992(4)
Authors: Tsuruta O.; Yuasa H.; Hashimoto H.

Utilization of wieland furoxan synthesis for preparation of 4-aryl-1,2,5-oxadiazole-3-yl carbamate derivatives having potent anti-HIV activity
pp. 1993-1996(4)
Authors: Takayama H.; Shirakawa S.; Kitajima M.; Aimi N.; Yamaguchi K.; Hanasaki Y.; Ide T.; Katsuura K.; Fujiwara M.; Ijichi K.; Konno K.; Sigeta S.; Yokota T.; Baba M.

Synthesis of a chemiluminescent probe useful for the purification of steroid 5-reductase
pp. 1997-2002(6)
Authors: Guarna A.; Poletti A.; Catrambone F.; Danza G.; Marrucci A.; Serio M.; Celotti F.; Martini L.

Identification and stereochemistry of the product of 4-HPPD catalyzed oxidation of the ketoacid of methionine
pp. 2003-2006(4)
Authors: Adlington R.M.; Baldwin J.E.; Crouch N.P.; Meng-Huee L.; MacKinnon C.H.

Solid phase synthesis of peptides containing a phosphoserine - sulfur mustard adduct
pp. 2007-2012(6)
Authors: Noort D.; Platenburg D.H.J.M.; Benschop H.P.

Diphenylmethyl ethers: synthesis and histamine H₃-receptor antagonist in vitro and in vivo activity
pp. 2013-2018(6)
Authors: Huls A.; Purand K.; Stark H.; Ligneau X.; Arrang J.-M.; Schwartz J.-C.; Schunack W.

Synthesis and biological evaluation of 4-alkoxy substituted trinems. Part I
pp. 2019-2024(6)
Authors: Andreotti D.; Biondi S.; Di Fabio R.; Donati D.; Piga E.; Rossi T.

Synthesis and biological evaluation of 4-alkoxysubstituted trinems. Part II
pp. 2025-2030(6)
Authors: Di Fabio R.; Andreotti D.; Biondi S.; Gaviraghi G.; Rossi T.

Novel antifungal 2-aryl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives with high activity against aspergillus fumigatus.
pp. 2031-2036(6)
Authors: Dickinson R.P.; Bell A.S.; Hitchcock C.A.; Narayanaswami S.; Ray S.J.; Richardson K.; Troke P.F.

The synthesis and biological evaluation of hypericin analogs, Bioorganic & Medicinal Chemistry Letters
pp. 2037-2037(1)
Authors: Kraus G.A.; W. Z.; Carpenter S.